Neurobiology and Genetics of Mental Disorders — MCQs
On this page
A 45-year-old male's blood test shows an increase in Homovanillic acid (HVA). Which of the following conditions is this finding most likely associated with?
Which of the following features is NOT commonly associated with 22q11.2 deletion syndrome?
Which chromosome is associated with bipolar disease?
A 45-year-old male's blood work shows decreased levels of Homovanillic acid (HVA). This patient is most likely to exhibit which of the following conditions?
What are the most important receptors implicated in schizophrenia?
A 25-year-old male patient sustains a serious head injury in an automobile accident. He had been aggressive and assaultive. He also makes inappropriate suggestive comments to the nurses and masturbates a great deal. The area(s) of the brain most likely to be affected in this patient is (are) the:
A 32-year-old woman is diagnosed with major depression. What is the chance that her identical twin sister will develop the same disease?
IQ related genes have recently been found on which chromosome?
Increased suicidal tendency is associated with which of the following neurotransmitters?
Stimulation of which of the following nerves causes an elevation in mood?
Neurobiology and Genetics of Mental Disorders Indian Medical PG Practice Questions and MCQs
Question 1: A 45-year-old male's blood test shows an increase in Homovanillic acid (HVA). Which of the following conditions is this finding most likely associated with?
- A. Phenylketonuria (PKU)
- B. Schizophrenia (Correct Answer)
- C. Depression
- D. Parkinson's disease
Explanation: **Explanation:** The correct answer is **Schizophrenia**. This question tests your knowledge of neurotransmitter metabolites and their clinical significance in psychiatric disorders. **1. Why Schizophrenia is correct:** **Homovanillic acid (HVA)** is the primary metabolic byproduct of **Dopamine**. According to the **Dopamine Hypothesis of Schizophrenia**, the disorder is characterized by dopaminergic hyperactivity, particularly in the mesolimbic pathway. Increased turnover of dopamine leads to elevated levels of HVA in the blood, cerebrospinal fluid (CSF), and urine. Monitoring HVA levels is often used in research to gauge central dopamine activity. **2. Why the other options are incorrect:** * **Phenylketonuria (PKU):** This is a metabolic disorder caused by a deficiency of phenylalanine hydroxylase. It leads to an accumulation of Phenylalanine, not HVA. * **Depression:** Depression is primarily associated with decreased levels of **5-HIAA** (5-Hydroxyindoleacetic acid), which is the metabolite of Serotonin. While dopamine can be involved, HVA is not a diagnostic marker for depression. * **Parkinson’s Disease:** This condition involves the degeneration of dopaminergic neurons in the substantia nigra. Therefore, one would expect a **decrease** in HVA levels due to dopamine deficiency, rather than an increase. **High-Yield Clinical Pearls for NEET-PG:** * **Dopamine → HVA** (Homovanillic Acid) * **Serotonin → 5-HIAA** (Decreased in suicide attempts and impulsive aggression) * **Norepinephrine → VMA** (Vanillylmandelic Acid) and **MHPG** (3-methoxy-4-hydroxyphenylglycol). * **VMA** is a crucial marker for diagnosing **Pheochromocytoma** and **Neuroblastoma**. * In Schizophrenia, HVA levels often correlate with the severity of positive symptoms (hallucinations/delusions).
Question 2: Which of the following features is NOT commonly associated with 22q11.2 deletion syndrome?
- A. Mental retardation (Correct Answer)
- B. Schizophrenia
- C. ADHD
- D. Congenital heart defects
Explanation: **Explanation:** **22q11.2 Deletion Syndrome** (also known as DiGeorge or Velocardiofacial Syndrome) is the most common microdeletion syndrome in humans. The correct answer is **Mental retardation (Option A)** because, while patients frequently exhibit borderline intellectual functioning or learning disabilities, global "mental retardation" (moderate to severe intellectual disability) is **not** a defining or universal feature of the syndrome. Most patients have an IQ in the 70–85 range. **Analysis of Incorrect Options:** * **Schizophrenia (Option B):** This is a hallmark psychiatric association. Approximately 25–30% of individuals with this deletion develop schizophrenia, making it one of the strongest known genetic risk factors for the disorder. * **ADHD (Option C):** Neurodevelopmental disorders are highly prevalent; ADHD is the most common psychiatric diagnosis in children with 22q11.2 deletion, affecting roughly 30–40% of patients. * **Congenital heart defects (Option D):** These are classic physical manifestations, particularly conotruncal defects (e.g., Tetralogy of Fallot, interrupted aortic arch), occurring in about 75% of cases. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic (CATCH-22):** **C**ardiac defects, **A**bnormal facies, **T**hymic hypoplasia (T-cell deficiency), **C**left palate, **H**ypocalcemia (hypoparathyroidism), due to **22**q11 deletion. * **Psychiatry Link:** It is often tested as the "genetic link to schizophrenia." * **Diagnosis:** Confirmed via **FISH** (Fluorescence In Situ Hybridization) or chromosomal microarray. * **Key Gene:** The **TBX1** gene is primarily responsible for the physical phenotypes.
Question 3: Which chromosome is associated with bipolar disease?
- A. Chromosome 16
- B. Chromosome 13 (Correct Answer)
- C. Chromosome 14
- D. Chromosome 11
Explanation: **Explanation:** Bipolar Disorder (BD) is a highly heritable psychiatric condition with a complex polygenic inheritance pattern. Genetic linkage studies have consistently identified specific loci associated with an increased susceptibility to the disorder. **1. Why Chromosome 13 is Correct:** Chromosome **13q** (specifically the 13q32 locus) is one of the most strongly linked regions to Bipolar Disorder. This region contains the **G72 (DAOA)** gene, which is involved in glutamatergic neurotransmission. Mutations or polymorphisms in this area are associated with both Bipolar Disorder and Schizophrenia, suggesting a shared genetic vulnerability between psychotic and mood disorders. **2. Analysis of Incorrect Options:** * **Chromosome 16 (Option A):** While some studies suggest minor links to various psychiatric traits, it is not a primary or high-yield locus specifically associated with Bipolar Disorder in standard medical curricula. * **Chromosome 14 (Option B):** This chromosome is most famously associated with **Early-onset Alzheimer’s Disease** (Presenilin-1 gene located at 14q24.3). * **Chromosome 11 (Option D):** Chromosome 11 is significant in psychiatry for the **BDNF** (Brain-Derived Neurotrophic Factor) gene and the **DRD4** gene, but Chromosome 13 remains the more classic "textbook" answer for linkage studies in Bipolar Disorder. **Clinical Pearls for NEET-PG:** * **Other Linked Chromosomes:** Besides 13q, Chromosomes **18q, 21q, and 22q** are frequently cited in association with Bipolar Disorder. * **Heritability:** Bipolar Disorder has the highest heritability among major psychiatric disorders (approx. 80-85%). * **Twin Studies:** If one monozygotic twin has Bipolar I disorder, there is a **40-70%** chance the other twin will also be affected. * **First-degree relatives:** They have a 5-10 times higher risk of developing the disorder compared to the general population.
Question 4: A 45-year-old male's blood work shows decreased levels of Homovanillic acid (HVA). This patient is most likely to exhibit which of the following conditions?
- A. Hyperventilation Syndrome
- B. Schizophrenia
- C. Depression (Correct Answer)
- D. Parkinson's disease
Explanation: **Explanation:** The correct answer is **Depression**. **1. Understanding the Core Concept:** Homovanillic acid (HVA) is the primary metabolic byproduct of **Dopamine**. In psychiatry and neurology, HVA levels in the cerebrospinal fluid (CSF) or urine serve as a peripheral marker for central dopaminergic activity. * **Depression:** While traditionally linked to Serotonin (5-HIAA) and Norepinephrine (VMA/MHPG), research consistently shows that a subset of patients with depression (particularly melancholic or retarded depression) exhibits decreased dopaminergic activity, leading to low HVA levels. This correlates with symptoms like anhedonia and psychomotor retardation. **2. Analysis of Incorrect Options:** * **Hyperventilation Syndrome:** This is an anxiety-related respiratory condition. It is associated with respiratory alkalosis and decreased ionized calcium, not specific alterations in dopamine metabolites. * **Schizophrenia:** According to the Dopamine Hypothesis, schizophrenia is associated with *increased* dopaminergic activity in the mesolimbic pathway. Therefore, one would expect **increased** or normal HVA levels, not decreased. * **Parkinson’s Disease:** While Parkinson’s involves a loss of dopaminergic neurons in the substantia nigra, HVA is primarily used as a diagnostic marker in **psychiatric research** contexts. In the context of NEET-PG, if "Depression" and "Parkinson's" are both present, Depression is often the preferred answer for biochemical metabolite questions unless the question specifically mentions motor symptoms or CSF analysis. **3. High-Yield Clinical Pearls for NEET-PG:** * **5-HIAA (5-Hydroxyindoleacetic acid):** Decreased in the CSF of patients with impulsive aggression and **suicidal intent**. * **VMA (Vanillylmandelic acid):** Urinary metabolite of Epinephrine/Norepinephrine; elevated in **Pheochromocytoma**. * **MHPG:** Metabolite of Norepinephrine; decreased in certain subtypes of Depression. * **Dopamine Pathways:** Remember that the *Mesolimbic* pathway is linked to positive symptoms of Schizophrenia, while the *Nigrostriatal* pathway is linked to Parkinsonism.
Question 5: What are the most important receptors implicated in schizophrenia?
- A. GABAA
- B. GABAB
- C. D2 (Correct Answer)
- D. 5-HT1
Explanation: **Explanation:** The neurobiology of schizophrenia is primarily explained by the **Dopamine Hypothesis**, which posits that symptoms arise from dysregulated dopaminergic activity. Specifically, the **Dopamine D2 receptor** is the most critical target because: 1. **Hyperdopaminergia** in the mesolimbic pathway (excess D2 stimulation) is associated with **positive symptoms** (hallucinations, delusions). 2. All currently available antipsychotics (both typical and atypical) share the common property of being **D2 receptor antagonists**. The clinical potency of typical antipsychotics (e.g., Haloperidol) is directly proportional to their D2 receptor binding affinity. **Analysis of Incorrect Options:** * **GABAA & GABAB (Options A & B):** While GABAergic dysfunction (inhibitory deficits) is observed in schizophrenia research, these receptors are not the primary targets for treatment. GABA receptors are more centrally involved in the mechanism of benzodiazepines and the pathophysiology of anxiety and seizure disorders. * **5-HT1 (Option D):** While serotonin (5-HT) plays a role in schizophrenia (especially **5-HT2A** antagonism in atypical antipsychotics like Clozapine), 5-HT1 is not the primary receptor implicated in the core disease process or the standard mechanism of antipsychotic efficacy. **NEET-PG Clinical Pearls:** * **Mesolimbic Pathway:** Increased D2 activity → Positive symptoms. * **Mesocortical Pathway:** Decreased D1/D2 activity → Negative symptoms (apathy, withdrawal). * **Nigrostriatal Pathway:** D2 blockade here by antipsychotics leads to **Extrapyramidal Side Effects (EPS)**. * **Tuberoinfundibular Pathway:** D2 blockade here leads to **Hyperprolactinemia**.
Question 6: A 25-year-old male patient sustains a serious head injury in an automobile accident. He had been aggressive and assaultive. He also makes inappropriate suggestive comments to the nurses and masturbates a great deal. The area(s) of the brain most likely to be affected in this patient is (are) the:
- A. right parietal lobe
- B. basal ganglia
- C. hippocampus
- D. amygdala (Correct Answer)
Explanation: ### Explanation The clinical presentation described—**hypersexuality** (inappropriate comments, excessive masturbation) and **hyperaggressiveness** (assaultive behavior)—is characteristic of damage to the **amygdala** and the associated limbic circuits. **1. Why the Amygdala is Correct:** The amygdala is the primary center for processing emotions and regulating primal drives. Bilateral lesions or dysfunction of the amygdala (and the adjacent temporal lobes) lead to **Klüver-Bucy Syndrome**. Key features of this syndrome include: * **Hypersexuality:** Loss of social inhibition regarding sexual behavior. * **Placidity or Hyperaggression:** Loss of normal fear responses or paradoxical outbursts of rage. * **Hyperorality:** A tendency to examine objects by mouth. * **Visual Agnosia:** Inability to recognize familiar objects. **2. Why the Other Options are Incorrect:** * **Right Parietal Lobe:** Damage here typically results in **hemispatial neglect** (ignoring the left side of the body/space), constructional apraxia, and disturbances in body image, rather than behavioral/sexual disinhibition. * **Basal Ganglia:** Primarily involved in motor control and habit formation. Dysfunction manifests as movement disorders (e.g., tremors in Parkinson’s or chorea in Huntington’s) or OCD-like symptoms, not primary hypersexuality. * **Hippocampus:** Primarily responsible for **memory consolidation** (converting short-term to long-term memory). Damage leads to anterograde amnesia (e.g., Patient HM). **Clinical Pearls for NEET-PG:** * **Klüver-Bucy Syndrome** is most commonly associated with **Herpes Simplex Encephalitis (HSE)**, which has a predilection for the temporal lobes. * The **Orbitofrontal Cortex** is another high-yield area; damage there also causes disinhibition and personality changes (e.g., the Phineas Gage case), but the specific combination of aggression and hypersexuality strongly points to the amygdala/limbic system. * **Wernicke-Korsakoff Syndrome** involves the mammillary bodies and dorsomedial nucleus of the thalamus, presenting with ataxia, ophthalmoplegia, and confabulation.
Question 7: A 32-year-old woman is diagnosed with major depression. What is the chance that her identical twin sister will develop the same disease?
- A. 5%
- B. 25%
- C. 50% (Correct Answer)
- D. 75%
Explanation: ### Explanation **Concept: Genetic Concordance in Mood Disorders** The correct answer is **50%**. In psychiatric genetics, "concordance rate" refers to the probability that one twin will develop a disorder if the other twin has it. For Major Depressive Disorder (MDD), studies consistently show a concordance rate of approximately **50% for Monozygotic (MZ) twins** (identical) and about **20% for Dizygotic (DZ) twins** (fraternal). This significant difference between MZ and DZ twins highlights a strong genetic component, though the fact that MZ concordance is not 100% indicates that environmental factors also play a crucial role. **Analysis of Options:** * **Option A (5%):** This is closer to the general population's lifetime risk for certain specific disorders but is far too low for a first-degree relative or identical twin of an MDD patient. * **Option B (25%):** This is roughly the risk for **Dizygotic twins** or first-degree relatives (parents/siblings) of a patient with MDD (approx. 15-25%). * **Option D (75%):** This rate is more characteristic of **Bipolar Disorder** in Monozygotic twins, which has a much higher genetic loading (concordance rates typically range from 60% to 90%). **NEET-PG High-Yield Pearls:** * **Bipolar Disorder (BPAD):** Highest genetic link in psychiatry. MZ twin concordance is **~70-90%**; if one parent has BPAD, the risk to the child is **10-15%**; if both parents have it, the risk rises to **40%**. * **Schizophrenia:** MZ twin concordance is **~40-50%** (similar to MDD). If both parents are affected, the risk is **~40-46%**. * **General Rule:** If a question asks for MZ concordance in MDD or Schizophrenia, think **50%**. If it asks for Bipolar Disorder, think **higher (75%+)**.
Question 8: IQ related genes have recently been found on which chromosome?
- A. Chromosome 21
- B. Chromosome X (Correct Answer)
- C. Chromosome 10
- D. Chromosome 18
Explanation: **Explanation:** The correct answer is **Chromosome X**. Intelligence is a complex polygenic trait, but research in behavioral genetics has consistently highlighted the disproportionate role of the X chromosome in determining IQ. **Why Chromosome X is correct:** The X chromosome contains a high density of genes related to brain development, synaptic plasticity, and cognitive function. It is estimated that the X chromosome contains approximately **three times more genes** linked to mental function than any other autosome. This genetic concentration explains why many forms of intellectual disability (e.g., Fragile X Syndrome) are X-linked and why there is a higher prevalence of both very high and very low IQ scores among males (the "Greater Male Variability Hypothesis"). **Analysis of Incorrect Options:** * **Chromosome 21:** While Trisomy 21 (Down Syndrome) is the most common chromosomal cause of intellectual disability, the chromosome itself is not considered the primary "hub" for general intelligence genes in the healthy population. * **Chromosome 10 & 18:** While various loci on these chromosomes have been implicated in psychiatric conditions (such as bipolar disorder or schizophrenia), they do not harbor the specific concentration of cognitive-related genes found on the X chromosome. **High-Yield Clinical Pearls for NEET-PG:** * **X-linked Intellectual Disability (XLID):** Over 100 genes on the X chromosome are known to cause intellectual disability when mutated. * **Fragile X Syndrome:** The most common inherited cause of intellectual disability, caused by a CGG trinucleotide repeat expansion on the **FMR1 gene** (located on the X chromosome). * **Heritability of IQ:** The heritability of intelligence increases with age, ranging from ~20% in infancy to ~80% in late adulthood.
Question 9: Increased suicidal tendency is associated with which of the following neurotransmitters?
- A. Noradrenaline
- B. Serotonin (Correct Answer)
- C. Dopamine
- D. GABA
Explanation: **Explanation:** The correct answer is **Serotonin (5-HT)**. The association between low serotonergic activity and suicidal behavior is one of the most robust findings in biological psychiatry. **1. Why Serotonin is Correct:** Research consistently shows that **decreased levels of Serotonin** (and its primary metabolite, **5-HIAA**, in the cerebrospinal fluid) are strongly linked to increased impulsivity, aggression, and completed suicide. This association holds true across various psychiatric diagnoses, including depression, schizophrenia, and personality disorders. Low 5-HIAA levels are considered a biological marker for "violent" suicide attempts. **2. Why Other Options are Incorrect:** * **Noradrenaline (A):** While dysregulation of the norepinephrine system is involved in the stress response and arousal patterns of depression, it is not the primary neurotransmitter linked specifically to the *tendency* or *impulse* of suicide. * **Dopamine (C):** Dopamine is primarily associated with the reward system, motivation, and motor control. While reduced dopaminergic activity is linked to anhedonia (inability to feel pleasure), it is not the definitive marker for suicidal behavior. * **GABA (D):** GABA is the brain's primary inhibitory neurotransmitter. While GABAergic dysfunction is implicated in anxiety and sleep disorders, it does not have the same direct, evidence-based correlation with suicidal intent as serotonin. **3. High-Yield Clinical Pearls for NEET-PG:** * **Metabolite Marker:** Low **5-HIAA** (5-Hydroxyindoleacetic acid) in CSF is the most high-yield laboratory finding associated with violent suicide. * **Post-mortem finding:** Studies of suicide victims often show decreased serotonin receptor binding in the **ventromedial prefrontal cortex**. * **Genetics:** Polymorphisms in the **Tryptophan Hydroxylase (TPH)** gene, the rate-limiting enzyme for serotonin synthesis, are often studied in relation to suicidal behavior. * **Antidepressants:** While SSRIs increase serotonin, patients should be monitored closely during the first 2 weeks of treatment, as an increase in physical energy may precede the improvement in mood, potentially providing the "energy" to act on suicidal ideation.
Question 10: Stimulation of which of the following nerves causes an elevation in mood?
- A. Olfactory Nerve
- B. Optic Nerve
- C. Trigeminal Nerve
- D. Vagus Nerve (Correct Answer)
Explanation: **Explanation:** The correct answer is **Vagus Nerve (Cranial Nerve X)**. **Vagus Nerve Stimulation (VNS)** is an FDA-approved neuromodulation therapy for treatment-resistant depression. The underlying medical concept involves the stimulation of the afferent fibers of the vagus nerve, which project to the **nucleus tractus solitarius (NTS)** in the medulla. From the NTS, signals are sent to key mood-regulating areas of the brain, including the **locus coeruleus** (increasing norepinephrine) and the **raphe nuclei** (increasing serotonin). This modulation of neurotransmitter systems and the limbic system results in an antidepressant effect and elevation of mood. **Why other options are incorrect:** * **Olfactory (CN I) and Optic (CN II) Nerves:** These are purely sensory nerves dedicated to smell and vision, respectively. While sensory experiences can influence mood, direct electrical stimulation of these nerves is not a recognized clinical treatment for mood disorders. * **Trigeminal Nerve (CN V):** While Trigeminal Nerve Stimulation (TNS) is being researched for epilepsy and ADHD, it is not the primary or established "gold standard" cranial nerve stimulation used for mood elevation in psychiatric practice compared to the Vagus nerve. **High-Yield Clinical Pearls for NEET-PG:** * **VNS Indications:** Used for Treatment-Resistant Depression (TRD) and refractory epilepsy. * **Mechanism:** Increases levels of Norepinephrine and Serotonin in the brain. * **Side Effects of VNS:** Most common include hoarseness of voice, cough, and throat pain (due to proximity to the recurrent laryngeal nerve). * **Other Neuromodulation:** Do not confuse VNS with **Deep Brain Stimulation (DBS)**, which targets the Subgenual Cingulate Cortex (Area 25) for depression.
Practice by Chapter
Neuroanatomy for Psychiatry
Practice Questions
Neurotransmitters and Receptors
Practice Questions
Neuroimaging in Psychiatry
Practice Questions
Neuropsychological Assessment
Practice Questions
Genetics of Psychiatric Disorders
Practice Questions
Epigenetics in Psychiatry
Practice Questions
Psychoneuroimmunology
Practice Questions
Circadian Rhythms and Psychiatry
Practice Questions
Neurodevelopmental Perspectives
Practice Questions
Stress and HPA Axis
Practice Questions
Gene-Environment Interactions
Practice Questions
Biomarkers in Psychiatry
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free